Pro Medicus Limited (ASX:PME)
213.77
+4.12 (1.97%)
Jul 6, 2026, 4:10 PM AEST
Pro Medicus Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Pro Medicus stock has a consensus rating of "Buy" and an average price target of $181.77. The average 1-year stock price forecast is 14.97% lower than the current stock price, while the lowest is $54.00 (-74.74%) and the highest is $245.00 (+14.61%).
Price Target: $181.77 (-14.97%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 2, 2026.
Analyst Ratings
The average analyst rating for Pro Medicus stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 9 | 9 | 8 |
| Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Hold | 4 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 13 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains $221.00 | Buy | Maintains | $221.00 | +3.38% | Jun 2, 2026 |
| Morgans | Morgans | Buy Maintains $210.00 | Buy | Maintains | $210.00 | -1.76% | Jun 2, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $195.00 | Hold | Maintains | $195.00 | -8.78% | Jun 1, 2026 |
| Jefferies | Jefferies | Buy Maintains $147.00 | Buy | Maintains | $147.00 | -31.23% | May 25, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $207.90 | Buy | Maintains | $207.90 | -2.75% | May 19, 2026 |
Financial Forecast
Revenue This Year
261.58M
from 212.98M
Increased by 22.82%
Revenue Next Year
333.68M
from 261.58M
Increased by 27.56%
EPS This Year
1.36
from 1.14
Increased by 19.28%
EPS Next Year
1.79
from 1.36
Increased by 31.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 278.4M | ||
| Avg | 261.6M | ||
| Low | 252.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.7% | ||
| Avg | 22.8% | ||
| Low | 18.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.44 | ||
| Avg | 1.36 | ||
| Low | 1.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.4% | ||
| Avg | 19.3% | ||
| Low | 14.1% |